001     858935
005     20210130000137.0
024 7 _ |a 10.1039/9781788013062-00368
|2 doi
037 _ _ |a FZJ-2018-07771
100 1 _ |a Willuweit, A.
|0 P:(DE-Juel1)144347
|b 0
|e Corresponding author
245 _ _ |a CHAPTER 19. Preclinical Applications of MR-PET
260 _ _ |a Cambridge
|c 2018
|b Royal Society of Chemistry
295 1 0 |a Hybrid MR-PET Imaging / Shah, N Jon (Editor) doi:10.1039/9781788013062
300 _ _ |a 368 - 378
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1553864860_28546
|2 PUB:(DE-HGF)
490 0 _ |a New Developments in NMR
520 _ _ |a Combined magnetic resonance-positron emission tomography (MR-PET), acquired either simultaneously in hybrid scanners or sequentially with standalone machines, offers various applications for preclinical studies. For example, in order to develop new diagnostic tools for translation into the clinic, proof-of-concept studies enable the development and implementation of new hardware components and MRI sequences. New PET tracers and contrast agents can also be applied and cross-validated with either modality. Currently, dual-probes are under development, which synergistically combine the advantages of imaging agents from PET and magnetic resonance imaging. MR-PET is also being implemented more frequently to support the monitoring of preclinical treatment studies for the development of new therapeutic agents and strategies. Further applications of combined MR-PET are multi-modal validation studies of new animal models and analysis of brain function and disease mechanisms, which can be monitored longitudinally.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef Book Series
700 1 _ |a Lohmann, P.
|0 P:(DE-Juel1)145110
|b 1
700 1 _ |a Stegmayr, C.
|0 P:(DE-Juel1)156479
|b 2
773 _ _ |a 10.1039/9781788013062-00368
787 0 _ |a Shah, N. J.
|d Cambridge : Royal Society of Chemistry, 2018
|i RelatedTo
|0 FZJ-2018-02194
|r
|t Hybrid MR-PET Imaging: Systems, Methods and Applications
856 4 _ |u https://juser.fz-juelich.de/record/858935/files/9781788013062-00368.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/858935/files/9781788013062-00368.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:858935
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)144347
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)145110
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)156479
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 0
920 1 _ |0 I:(DE-Juel1)INM-11-20170113
|k INM-11
|l Jara-Institut Quantum Information
|x 1
920 1 _ |0 I:(DE-82)080010_20140620
|k JARA-BRAIN
|l JARA-BRAIN
|x 2
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a I:(DE-Juel1)INM-11-20170113
980 _ _ |a I:(DE-82)080010_20140620
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21